|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
HEMATOPOIESIS
From the Department of Medicine II, University of
Tübingen, Germany.
Recent studies suggest that bone marrow (BM)-derived chemotactic
mediators such as chemokines play key roles in hematopoietic stem cell
trafficking. Lipid mediators, particularly leukotrienes, are involved
in leukocyte chemotaxis during inflammation but have also been detected
in the normal BM. Therefore, the effects of leukotrienes on
hematopoietic progenitor cells were analyzed. Cysteinyl leukotrienes,
particularly leukotriene D4 (LTD4), induced strong intracellular
calcium fluxes and actin polymerization in mobilized and BM
CD34+ progenitors. Chemotaxis and in vitro transendothelial
migration of CD34+ and more primitive
CD34+/CD38 Mechanisms involved in hematopoietic stem cell
trafficking have been largely unknown for a long time. During the past
few years, the role of particular secreted (eg, cytokines) and
cell-bound proteins (eg, adhesion molecules) in progenitor mobilization
and homing has been recognized.1-4 More recently, it has
been shown that cytokines with chemotactic effects (chemokines) may
play a central role in progenitor cell trafficking, particularly in stem cell homing to the bone marrow (BM).2,5-7
Interestingly, extravasation of mature leukocytes during inflammation
and homing of immature progenitor and stem cells to the BM may at least
partially depend on similar mechanisms.4 Inflamed tissues
and the hematopoietic microenvironment share similarities, such as
expression of particular adhesion molecules (E-selectin, vascular cell
adhesion molecule-1) on microvascular endothelium.8,9
However, inflammatory chemotaxis of leukocytes is not only controlled
by adhesion molecules and chemokines but also by nonpeptide mediators,
particularly by lipid mediators such as leukotrienes.10 One might therefore speculate that these mediators also play a role in
progenitor cell trafficking. During inflammation, phospholipases release arachidonic acid from the cell membranes of activated leukocytes, which is metabolized to leukotrienes via the 5-lipoxygenase pathway.10,11 The initial product, leukotriene (LT)A4, is
either hydrolized to LTB4 or conjugated with glutathione, providing the cysteinyl leukotriene LTC4, which is subsequently converted to LTD4 and
LTE4. Specific functions of leukotrienes are mediated by receptors with
distinct specificity, eg, the LTB4 receptor and the cysteinyl
leukotriene receptor CysLT1, which have recently been
identified.12,13 The finding that cysteinyl leukotrienes are produced in human BM supports their potential role in the hematopoietic microenvironment.14 Leukotrienes LTB4 and
LTC4 have been shown to stimulate growth of colony-forming
unit-granulocyte macrophage colonies in
methylcellulose.15 However, the effect of leukotrienes on
distinct progenitor cell populations (eg, immature progenitor cells)
has not been studied.
Cysteinyl leukotrienes have a number of pathophysiologic activities,
such as induction of proliferation and contraction of smooth muscle
cells, promotion of eosinophil migration, and increases in vascular
permeability.16-18 They are established as playing a major
role in inflammation, allergy, and asthma,10,19,20 but no
physiologic role has been described. Given the short half-life and
range in vivo,10 LTD4 could act as a paracrine or
autocrine mediator in the BM independent from its role in
inflammation and allergy.
Many effects of LTD4, the most potent of the cysteinyl leukotrienes,
are mediated through the recently cloned 7-transmembrane receptor
CysLT1.12,21 This receptor shows structural similarities (7 transmembrane domains) to several chemokine receptors, including CXCR4, which is expressed on various cell types, including
CD34+ hematopoietic progenitor cells.6,22,23
The glycosylated receptor CysLT124 is coupled to pertussis
toxin (PTX)-sensitive and -insensitive G proteins, indicating that
different signal transduction pathways may mediate various
activities.25 LTD4 activation results in a transient
mobilization of intracellular calcium in the target
cells.26,27 The LTD4-mediated effects can be
inhibited by several specific CysLT1 receptor antagonists, such as
montelukast, zafirlukast, pranlukast, and MK-571, which are
successfully used in treatment of allergic asthma.28-32
The functional role of additional cysteinyl leukotriene receptors (eg,
CysLT2), which are not blocked by these antagonists, remains to
be characterized.33
In the present study, we investigated the effect of leukotrienes on
circulating CD34+ progenitors, mature granulocytes, and
leukemic cell lines. In these cells, expression of the LTD4 receptor
CysLT1 and postreceptor effects were measured, ie, intracellular
calcium mobilization, actin polymerization, and chemotaxis. In
addition, we determined expression of 5-lipoxygenase, the key enzyme of
leukotriene biosynthesis, to evaluate whether progenitor cells could
also contribute to leukotriene production in the hematopoietic microenvironment.
Leukotrienes, CysLT1 antagonist
Cell lines and BM stromal cells
Isolation of CD34+ hematopoietic progenitors After informed consent, peripheral blood (PB) mononuclear cells (MNCs) were obtained from patients with nonhematologic malignancies or normal stem cell donors during PB progenitor cell mobilization with granculocyte colony-stimulating factor. BM aspirates from healthy donors served as a source for BM MNCs. MNCs were separated by Ficoll density gradient centrifugation. The CD34+ cells were isolated using immunomagnetic microbeads (MACS System, Miltenyi Biotec, Bergisch Gladbach, Germany). Samples with a purity of at least 98% (flow cytometry) were used for this study.Isolation of normal MNCs and granulocytes Isolation of PB MNCs and PB polymorphonuclear cells (PMNCs) was performed using dextran sedimentation and Ficoll density centrifugation as described previously.36 For the isolation of the granulocytes, the cell pellet was resuspended in 0.98% NH4Cl for lysis of residual erythrocytes37,38 and washed in phosphate-buffered saline (PBS). In accordance with previously published data,36 the purity of the PMNCs was more than 98%.Flow cytometry A total of 105 cells were incubated for 30 minutes at 4°C with the fluorescein isothiocyanate (FITC)- or phycoerythrin (PE)-conjugated monoclonal antibodies: CD34, CD38-PE, CD45 (Becton Dickinson, Heidelberg, Germany), and CD38-FITC (Coulter-Immunotech, Hamburg, Germany). Isotype-identical antibodies served as controls (immunoglobulin G1 and immunoglobulin G2, FITC/PE-conjugated; Becton Dickinson). Cells were analyzed using a FACSCalibur flow cytometer (Becton Dickinson). To calculate the percentage of positive cells, a proportion of 1% or fewer false-positive events was accepted in the negative control sample.Reverse transcriptase-polymerase chain reaction analysis Oligonucleotide primers for human CysLT1 were synthezised: 5'-GACAGCCATGAGCTTTTTCC-3' (sense), 5'-ATGCAGCCAGAGACAAGGTT-3' (antisense), resulting in a polymerase chain reaction (PCR) product of 514 base pairs (bp). For -actin, the sense primer
5'-TCATGTTTGAGACCTTCAA-3' and the antisense primer
5'-GTCTTTGCGGATGTCCACG-3' were used (513 bp). For investigation of
5-lipoxygenase messenger RNA (mRNA) expression,
5'-ACTGGAAACACGGCAAAAAC-3' served as sense and
5'-GTGCAGGGGTCTGTTTTGTT-3' as an antisense primer (501 bp). Total RNA
was isolated (Rneasy Mini Kit, Qiagen, Hilden, Germany) and transcribed
to complementary DNA (murine leukemia virus reverse transcriptase,
PerkinElmer, Langen, Germany). Complementary DNA PCR was performed as
described previously.6 The PCR profile consisted of
1-minute initial denaturation at 94°C, followed by 30 to 36 cycles of
40-second denaturation at 94°C, 1-minute annealing (58°C for CysLT1
and 55°C for -actin) or 30-second annealing (58°C for
5-lipoxygenase), 2-minute polymerization at 72°C and, finally,
10-minute extension at 72°C. As a control, each reaction was
additionally performed without addition of reverse transcriptase.
Western blot analysis Protein extracts were produced by dissolving the cellular proteins in Triton X-100 lysis buffer with protease inhibitors (leupeptin, aprotinin [Boehringer Mannheim, Mannheim, Germany]), 1 mM phenylmethylsulfonylfluoride (Sigma, St Louis, MO), and 1.8 mg/mL iodoacetamide (Sigma) for 45 minutes on ice. After centrifugation, the supernatants were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene fluoride membrane (Hybond-P, Amersham Pharmacia Biotech, Freiburg, Germany). After blocking of the membranes with PBS-T (PBS plus 0.1% Tween 20) plus 5% dry milk powder at 4°C, the blots were incubated with a goat-anti-CysLT1 polyclonal antibody (1:3000, kindly provided by Dr J. F. Evans39) for 1 hour at room temperature. Following 5 wash steps with PBS-T, the membranes were incubated with a polyclonal, horseradish peroxidase-conjugated rabbit-antigoat antibody (1:4000; Dako, Hamburg, Germany) for 1 hour. After washing, bound antibodies were detected using the enhanced chemiluminescence plus Western blotting detection system (Amersham).Measurement of intracellular calcium mobilization Intracellular free Ca++ was measured using the fluorescent calcium indicator Fluo-3 (Molecular Probes, Leiden, Netherlands), which was loaded into the cells as described previously.40,41 Cells (107/mL) were incubated in Hanks balanced salt solution (Sigma) containing 10 µM Fluo-3 for 30 minutes at 37°C. After a 1:5 dilution in Hanks balanced salt solution/1% fetal calf serum and a further incubation for 40 minutes at 37°C, the cells were washed 3 times, resuspended in HEPES-buffered saline (137 mM NaCl, 5 mM KCl, 1mM Na2HPO4, 5 mM glucose, 1 mM CaCl2, 0.5 mM MgCl2, 1 g/L bovine serum albumin, 10 mM HEPES, pH 7.4), and incubated for at least 10 minutes at 37°C. After stimulation with leukotrienes (LTB4, LTC4, LTD4, or LTE4) or SDF-1 (recombinant human SDF-1, R&D Systems,
Wiesbaden, Germany), the fluorescence (FITC channel) was continuously
analyzed using a FACSCalibur flow cytometer (Becton Dickinson) in
5-second acquisition intervals. As a control, fluorescence changes were measured after application of equal volumes of carrier solution. In
some experiments, blocking of the LTD4 receptor CysLT1 was performed by
adding MK-571, a specific CysLT1 receptor antagonist,28 at
a final concentration of 2 µM, 2 minutes prior to leukotriene application. To analyze the effects of PTX on the CysLT1 signal transduction pathway, the cells were preincubated with 1 µg/mL PTX
for 1.5 hours.
Measurement of polymerized F-actin Cells were suspended in X-VIVO20 medium (Biowhittaker, Walkersville, MD), and LTD4 was added (final concentration 1 µM). By adding 1 volume of FITC-phalloidine (Sigma) working solution (18% formaldehyde, 50 mg/mL lysophosphatidylcholine, 0.4 µM FITC conjugated phalloidine) to 4 volumes of cell suspension, polymerized F-actin was fluorescence labeled, and the cells were fixed and analyzed by flow cytometry (FACSCalibur, Becton Dickinson) as described previously.42,43Chemotaxis assay Chemotaxis of CD34+ progenitors was analyzed in a modified Boyden chamber system using 30 µL Chemotx 96-well microplates (Receptor Technologies, Adderbury, United Kingdom) with 5-µm membrane pores. The membrane was coated with fibronectin (10 µg/mL, 1 hour) and positioned over the wells, which had been loaded with X-VIVO20 serum-free medium (Biowhittaker) containing chemoattractants or solvent (control). For each well, 50 µL serum-free medium containing 3 × 104 CD34+ cells was pipetted onto the membrane. After a 14-hour incubation at 37°C and 5% CO2, the medium, including nonmigrated cells, was removed and the membrane was incubated with ethylenediaminetetraacetic acid solution (0.2%, 30 minutes, 4°C). After centrifugation (400g), the number of migrated cells was evaluated by colorimetric lactate dehydrogenase activity (Cytotox96, Promega, Mannheim, Germany).Transendothelial migration Migration across BM endothelial cells was quantitatively analyzed as described previously6 using BMEC-1 cells grown to confluency on 3-µm microporous Transwell inserts (Corning-Costar, Bodenheim, Germany) placed in 6-well tissue culture plates. LTD4 (50 nM) or SDF-1 (recombinant human SDF-1, R&D Systems; 500 ng/mL) was
added as a chemoattractant to the lower chamber and
5 × 105 CD34+ cells to the upper chamber of
the transmigration system. Transmigrated cells were recovered and
enumerated after 14 hours.
Statistical analysis For statistical analysis of calcium mobilization, actin polymerization, chemotaxis, and transendothelial migration assays, data from at least 3 independent experiments were expressed as mean ± SEM. For the assessment of statistical significance, the Wilcoxon matched pairs signed rank test was applied.
Expression of the LTD4 receptor CysLT1 in human CD34+ progenitor cells Expression of CysLT1 mRNA in CD34+ cells, mature leukocytes, and in cell lines was analyzed by reverse transcriptase-polymerase chain reaction (RT-PCR) (Figure 1A). Corresponding to indirect evidence from previously published data,25 the CD34-monocytic cell line THP-1 expressed CysLT1 mRNA and was therefore used as a positive control. In contrast, no expression of the specific CysLT1 mRNA was observed in the neuroblastoma cell line SK-N-LO, serving as a negative control. By RT-PCR, PB CD34+ hematopoietic progenitor cells, PMNCs, and MNCs expressed the CysLT1 mRNA, as well as the CD34+ progenitor cell line KG1a and the CD34-myeloid cell line HL-60. Analysis of-actin mRNA expression served as an internal
control. In accordance with the RT-PCR data, Western blot analysis
revealed a single band between the 30- and 46-kd weight markers in all samples, except the negative control cell line SK-N-LO (Figure 1B),
which was consistent with previously published results using the same
polyclonal antibody39 and corresponds to the calculated molecular mass of CysLT1 (38.5 kd).12 The strongest
expression of CysLT1 protein was observed in the CD34+ cell
line KG1a. In mobilized, circulating CD34+ cells, the
signal was at least as strong as in mature leukocytes (PMNCs, MNCs).
Because expression of CysLT1 in circulating CD34+ cells may
show interindividual differences, additional samples from 3 different
donors were investigated as shown in Figure 1C. All CD34+
cell samples analyzed were brightly positive for CysLT1 expression at a
similar level.
Leukotriene-mediated mobilization of intracellular free calcium in progenitor cells LTD4 (1 µM) induced a significant, transient increase of intracellular free calcium in PB CD34+ cells (Figure 2A), which was measured semiquantitatively as relative Fluo-3 mean fluorescence. Concentrations as low as 1 nM resulted in significant calcium mobilization (dose-response curve, Figure 2B). The cells showed weaker effects in response to LTC4 and LTE4 given in an equimolar concentration (1 µM). Calcium mobilization was not observed after application of LTB4 (Figure 2C). Interestingly, the effect of LTD4 was more pronounced in PB than in BM-derived CD34+ progenitors. Calcium fluxes were completely blocked by the specific CysLT1 receptor antagonist MK-571.28 Only partial inhibition was observed after preincubation of the cells with PTX (1 µg/mL) for 1.5 hours. Similarly, LTD4-induced calcium fluxes were observed in the control cell line THP-1 but even stronger in the CD34+ cell line KG1a. In contrast, LTB4 induced intracellular calcium fluxes in PMNCs as described previously,44 whereas the effect of LTD4 was less pronounced and not suppressed by MK-571. In SK-N-LO cells, none of the tested leukotrienes caused an intracellular calcium mobilization.
LTD4-induced actin polymerization, chemotaxis, and transendothelial migration of CD34+ hematopoietic progenitor cells Actin polymerization in response to LTD4 as an initial step in cell locomotion was analyzed (Figure 3). In both mobilized PB CD34+ progenitors and KG1a cells, application of 1 µM LTD4 immediately resulted in an approximately 40% increase of polymerized F-actin, which depolymerized to the baseline level within 2 minutes. Using a modified Boyden chamber chemotaxis assay, the chemotactic activity of LTD4 on CD34+ progenitor cells was analyzed. Figure 4A shows the mean relative migration of PB CD34+ progenitor cells in response to different LTD4 concentrations. The greatest migration rate was observed in response to 25 nM LTD4. However, the optimum concentrations were different in individual CD34+ samples, ranging from 10 to 75 nM. As shown in Figure 4B, LTD4 at a concentration of 50 nM added to the lower chamber of the in vitro assay of transendothelial migration increased the number of transmigrating PB- and BM-derived CD34+ cells approximately 2-fold.
Effect of LTD4 on primitive and more differentiated hematopoietic progenitor cells Expression of the surface molecule CD38 is associated with lineage commitment of hematopoietic progenitors, whereas absence or low expression of this antigen on CD34+ cells is characteristic for more primitive progenitor cells.45-48 Therefore, we analyzed whether the effects of LTD4 on CD34+ cells are related to the level of CD38 expression. Particularly, the response of more primitive CD34+/CD38low/ cells to this
cysteinyl leukotriene was assessed by counterstaining of isolated,
Fluo-3-loaded progenitors with CD38-PE and analysis of the
LTD4-mediated intracellular calcium mobilization and CD38 expression by
flow cytometry. The transient shift of the Fluo-3 fluorescence, caused
by the intracellular calcium flux, was observed in both the
CD38+ and the CD38low/ cells (Figure
5A). Corresponding results were obtained
by fluorescence-activated cell sorter analysis of CD34+
cells that migrated in response to LTD4 (chemotaxis assay) compared with spontaneously migrated cells (Figure 5B). The percentage of more
immature CD34+/CD38low/ cells was similar in
both populations (6.35% and 6.15%) as well as in the
CD34+ population initially used for the assay (5.25%).
Similar results were obtained in the transmigration assay. The
percentage of CD34+/CD38low/ cells among the
PB CD34+ progenitors migrating in response to LTD4
(7.1% ± 1.7%) tended to be even greater compared with the
spontaneously migrating cells (5.4% ± 2.0%) or initially isolated
CD34+ cells (6.4% ± 2.9%).
Comparison of the effects of LTD4 and SDF-1 on hematopoietic progenitor cells We compared the effects of LTD4 on calcium mobilization and transendothelial migration with the chemokine SDF-1 in parallel experiments. Calcium fluxes (relative Fluo-3 fluorescence 5 seconds after addition of the ligand) in response to LTD4 (1 µM) were 3.0-fold ± 1.0-fold stronger than fluxes induced by saturating doses of SDF-1 (500 ng/mL), but the opposite result was observed regarding transendothelial migration. SDF-1 (500 ng/mL) augmented in vitro transendothelial migration of mobilized CD34+ cells 3.8-fold ± 0.7-fold more efficiently than LTD4 (50 nM).RT-PCR analysis of 5-lipoxygenase expression in hematopoietic progenitor cells Because 5-lipoxygenase is the key enzyme of leukotriene biosynthesis,10,11 RT-PCR analysis was performed to investigate the expression of 5-lipoxygenase mRNA in hematopoietic progenitor cells, cell lines, mature leukocytes, and primary human BM fibroblast-like stromal cells (Figure 6). As expected, mature PMNCs and MNCs were positive for the specific mRNA.10 Expression of 5-lipoxygenase mRNA was also observed in PB CD34+ and BM CD34+ progenitor cells, whereas primary BM fibroblast-like stromal cells as well as the neuroblastoma cell line SK-N-LO were negative for the specific PCR product. Analysis of CD34+ and CD34 leukemic
cell lines revealed only weak or negative PCR signals. As a control for
equal RNA amounts in the RT-reaction, -actin mRNA expression
was analyzed.
In this study, we demonstrate that CD34+ hematopoietic progenitor cells express the transmembrane receptor CysLT1, which mediates the effects of the lipid mediator LTD4. LTD4 induced calcium fluxes and actin polymerization in CD34+ progenitors and increased progenitor cell chemotaxis and in vitro transendothelial migration. Both PB- and BM-derived progenitors responded to LTD4. The specifity of these effects was demonstrated by abrogation of the calcium fluxes in the presence of the specific CysLT1 receptor antagonist MK-571.28 Until now, only CXCR4 has been described as a functionally active 7-transmembrane receptor expressed in CD34+ progenitors. However, CXCR4 is present on circulating progenitors at a relatively low level compared with mature leukocytes, and it is not detectable in most CD34+ progenitor cell lines such as KG1a.6 In contrast, CysLT1 is expressed in CD34+ cells at least as strong as in PMNCs or MNCs and in high levels in the CD34+ progenitor cell line KG1a. KG1a therefore represents a suitable positive control for the study of CysLT1 expression and may be a useful cell line for analysis of LTD4-mediated signal transduction pathways in hematopoietic progenitors, similar to the successful use of CXCR4-expressing progenitor cell lines in the investigation of SDF-1-mediated signal transduction.49 Chemotactic effects of LTD4 have previously been observed only in mature eosinophils and in neutrophils at high concentrations (10 µM).17,18 Our finding that MK-571 did not reduce the effects of LTD4 on calcium fluxes in mature granulocytes suggests that other LTD4 receptors, such as the recently identified CysLT2 receptor,33 mediate these effects, despite the fact that CysLT1 protein expression was also detected in granulocytes. However, circulating CD34+ cells respond to LTD4 with increased chemotaxis and transendothelial migration at an optimum concentration as low as 25 to 50 nM. Interestingly, in mature granulocytes, noncysteinyl leukotrienes such as LTB4, which were inactive in CD34+ progenitors, were more efficient than LTD4. These results demonstrate that during myeloid differentiation, a functionally active CysLT1 receptor is preferentially expressed in immature progenitors. The particular role of LTD4 for early myeloid development is supported by the fact that the key enzyme of leukotriene biosynthesis, 5-lipoxygenase, has been detected in the hematopoietic microenvironment,10,11 and production of cysteinyl leukotrienes has been found in human BM.14 CysLT1 belongs to the same group of G protein-coupled 7-transmembrane domain receptors12 as the SDF-1 receptor CXCR4. This receptor type is characteristic for a variety of chemokine receptors that share similar G protein-coupled signal transduction pathways resulting in a chemotactic response.22,23,50 Furthermore, LTD4 was able to induce a reorganization of the cytoskeleton by actin polymerization, which is an early step in cellular migration. The narrow bell-shaped LTD4 concentration optimum of the chemotactic effect (Figure 4) is in contrast with the sigmoidal dose-response relation of the calcium mobilization (Figure 2). Maximal intracellular calcium fluxes were observed at LTD4 concentrations more than one log step higher than required for optimum chemotactic responses of the progenitors. Interestingly, the intensity of the calcium-mobilizing effect of LTD4 on CD34+ cells at an optimum concentration (1 µM) was even stronger than that induced by optimal amounts of SDF-1, which has previously been described to induce intracellular calcium release.5 In contrast, transendothelial migration was more efficiently stimulated by SDF-1, which, however, could also be due to the short half-life and degradation of LTD4 in the transmigration assay. The LTD4 concentration required for optimal migration in the chemotaxis assay varied interindividually, which could indicate differences in the CysLT1 expression similar to expression of the chemokine receptor CXCR4 6 or might be due to partial down-regulation or receptor internalization dependent on the amount of cysteinyl leukotrienes actually present in the PB and bound to the receptor, which has similarly been described for other 7-transmembrane receptors.51 Expression of a functionally active LTD4 receptor on CD34+
cells suggests a role of this inflammatory lipid mediator in
hematopoiesis, particularly when considering the finding that already
low concentrations of LTD4 are sufficient to induce a chemotactic
response of progenitor cells. The concept that similar mechanisms
control inflammatory leukocyte extravasation and progenitor cell
trafficking is supported by the fact that other factors participating
in inflammation are also involved in progenitor cell homing to the
BM.1,3,4 For example, the adhesion molecule E-selectin
responsible for leukocyte rolling during inflammation is known to
contribute to chemokine-induced transendothelial migration of
CD34+ cells in vitro, which is prevented by an E-selectin
antibody.2 Furthermore, the integrin VLA-4 provoking the
firm adhesion of leukocytes to vascular endothelium at sites of
inflammation plays an important role in progenitor cell homing, as
shown in vivo using the fetal sheep model of in utero
transplantation.1 In the absence of inflammation, both
E-selectin and vascular cell adhesion molecule-1 (ligand of VLA-4) are
present preferentially on microvascular endothelium of the
BM.8,9 Thus, our results demonstrating interaction of
leukotrienes with their receptors on hematopoietic progenitor cells
indicate also that chemotaxis of progenitors might be controlled by
mechanisms that have previously been shown to regulate extravasation of
mature leukocytes during inflammation. It is unclear whether LTD4 and
CysLT1 are involved in stem cell homing, but the fact that
transplantation of fetal liver cells from CXCR4 Subset analysis of the LTD4-induced effects on CD34+ cells
was performed to determine whether more primitive progenitors also respond to LTD4, because most CD34+ cells represent
committed progenitors rather than immature, pluripotent cells with
repopulation capacity, and CysLT1 mRNA expression has also been
described in mature PB leukocytes.12,55 By costaining with
a PE-labeled CD38 antibody during the analysis of the calcium mobilization, we could show that more primitive
CD34+/CD38low/ Until now, cysteinyl leukotrienes have only been reported to play a role in the pathophysiology of inflammatory and allergic disorders, particularly in bronchial asthma.10,19,20 A physiologic role of these lipid mediators has not been established yet. The potential importance of cysteinyl leukotrienes as regulators of hematopoiesis is supported by the finding that mRNA expression of the CysLT1 receptor is greater in leukocytes and hematopoietic organs such as spleen than in lung tissue.12 Very short half-lives, particularly of LTD4,10 make them ideal candidates for short-range control of hematopoietic cell functions. RT-PCR analysis demonstrated that the key enzyme of leukotriene biosynthesis, 5-lipoxygenase, is expressed not only in mature leukocytes but also in PB and particularly in BM CD34+ cells. This raises the possibility that CD34+ cells not only respond to LTD4 but also produce this mediator in an autocrine or paracrine way. Signal transduction via CysLT1 involves both PTX-sensitive and -insensitive G proteins,25 which is in accordance with our finding that PTX only partially inhibits LTD4-induced calcium fluxes. Distinct signal transduction pathways could result in LTD4 effects on CD34+ cells other than chemotaxis, ie, effects on cell proliferation and differentiation,10 which might be controlled in an autocrine way. This idea is supported by the finding that inhibition of leukotriene biosynthesis after irradiation suppresses hematopoietic recovery.55 However, further studies are required to identify the source and regulation of leukotrienes produced in the BM.14 A recent study suggests that hematopoietic progenitor cells are involved in the early steps of leukotriene biosynthesis such as the release of arachidonate, but further metabolism to leukotrienes is probably mediated by other cell types.56 It is still an open question how the specificity of the homing process is realized, because a specific homing factor for stem cells has yet not been found. Adhesion molecules known to participate in the homing process are not exclusively expressed on BM endothelium or CD34+ cells. Also SDF-1 and its receptor CXCR4 are more broadly expressed and are also involved in embryogenesis, heart development, neuronal cell migration, and vascular development.54,57,58 Similarly, the expression of LTD4 and its receptor is not restricted to the hematopoietic microenvironment.12 However, the short in vivo range supports the idea that LTD4 is an ideal candidate mediator for the regulation of the spatial distribution of cells in the BM. The homing of CD34+ progenitor cells could therefore be mediated by a BM-specific combination of nonspecific factors, such as SDF-1, adhesion molecules, and other paracrine factors, including cysteinyl leukotrienes, rather than by a single factor alone.
We thank Christine Zimmermann for excellent techical assistance; Dr J. F. Evans, Department of Human Genetics, Merck Research Laboratories, West Point, PA, for generously providing the CysLT1 polyclonal antibody; and Dr R. N. Young, Merck Frosst Centre for Therapeutic Research, Quebec, Canada, for kindly providing MK-571.
Submitted August 21, 2000; accepted February 5, 2001.
Supported by grants from Deutsche Forschungsgemeinschaft (SFB 510).
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Robert Möhle, Dept of Medicine II, University of Tübingen, Otfried-Müller-Str 10, 72076 Tübingen, Germany; e-mail: robert.moehle{at}med.uni-tuebingen.de.
1.
Zanjani ED, Flake AW, Almeida-Porada G, Tran N, Papayannopoulou T.
Homing of human cells in the fetal sheep model: modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function.
Blood.
1999;94:2515-2522
2.
Naiyer AJ, Jo DY, Ahn J, et al.
Stromal derived factor-1-induced chemokinesis of cord blood CD34+ cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin.
Blood.
1999;94:4011-4019
3.
Greenberg AW, Kerr WG, Hammer DA.
Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development.
Blood.
2000;95:478-486 4. Möhle R, Bautz F, Rafii S, Moore MAS, Brugger W, Kanz L. Regulation of transendothelial migration of hematopoietic progenitor cells. Ann N Y Acad Sci. 1999;872:176-186[CrossRef][Medline] [Order article via Infotrieve].
5.
Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC.
The chemokine SDF-1 is a chemoattractant for human hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.
J Exp Med.
1997;185:111-120
6.
Möhle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L.
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.
Blood.
1998;91:4523-4530
7.
Peled A, Petit I, Kollet O, et al.
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR-4.
Science.
1999;283:845-848
8.
Jacobsen K, Kravitz J, Kincade PW, Osmond DG.
Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinosoidal endothelium in normal and gamma-irradiated mice.
Blood.
1996;87:73-82 9. Schweitzer KM, Drager AM, vanderValk P, et al. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol. 1996;148:165-175[Abstract]. 10. Denzlinger C. Biology and pathophysiology of leukotrienes. Crit Rev Oncol Hematol. 1996;23:167-223[Medline] [Order article via Infotrieve]. 11. Ford-Hutchinson AW, Gresser M, Young RN. 5-Lipoxygenase. Annu Rev Biochem. 1994;63:282-417. 12. Lynch KR, O'Neill GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 1999;399:789-793[CrossRef][Medline] [Order article via Infotrieve]. 13. Yokomizu T, Izumi T, Chang K, Takuwa Y, Shimizu T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature. 1997;387:620-624[CrossRef][Medline] [Order article via Infotrieve]. 14. Lindgren JA, Stenke L, Mansour M, et al. Formation and effects of leukotrienes and lipoxins in human bone marrow. J Lipid Mediat. 1993;6:313-320[Medline] [Order article via Infotrieve]. 15. Dupuis F, Desplat V, Praloran V, Denizot Y. Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. J Lipid Mediat Cell Signal. 1997;16:117-125[CrossRef][Medline] [Order article via Infotrieve].
16.
Panettieri RA, Tan EM, Ciocca V, Luttmann MA, Leonard TB, Hay DW.
Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensivity to cysteinyl leukotriene receptor antagonists.
Am J Respir Cell Mol Biol.
1998;19:453-461 17. Spada CS, Nieves AL, Krauss AH, Woodward DF. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol. 1994;55:183-191[Abstract]. 18. Chan CC, McKee K, Tagari P, Chee P, Ford-Hutchinson A. Eosinophil-eicosanoid interactions: inhibition of eosinophil chemotaxis by a LTD4-receptor antagonist. Eur J Pharmacol. 1990;191:273-280[CrossRef][Medline] [Order article via Infotrieve]. 19. Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 1980;288:484-486[CrossRef][Medline] [Order article via Infotrieve]. 20. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med. 1990;323:645-655[Medline] [Order article via Infotrieve].
21.
Sarau HM, Ames RS, Chambers J, et al.
Identification, molecular cloning, and characterization of a cysteinyl leukotriene receptor.
Mol Pharmacol.
1999;56:657-663 22. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for lestr/fusin and blocks HIV-1 entry. Nature. 1996;382:829-832[CrossRef][Medline] [Order article via Infotrieve]. 23. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for lestr/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 1996;382:833-835[CrossRef][Medline] [Order article via Infotrieve].
24.
Metters KM, Zamboni RJ.
Photoaffinity labeling of the leukotriene D4 receptor in guinea pig lung.
J Biol Chem.
1993;268:6487-6495
25.
Hoshino M, Izumi T, Shimizu T.
Leukotriene D4 activates mitogen-activated protein kinase through a protein kinase Calpha-Raf-1-dependent pathway in human monocytic leukemia THP-1 cells.
J Biol Chem.
1998;273:4878-4882 26. Crooke ST, Mattern M, Sarau HM, et al. The signal transduction system of the leukotriene D4 receptor. Trends Pharmacol Sci. 1989;10:103-107[CrossRef][Medline] [Order article via Infotrieve].
27.
Chan CC, Ecclestone P, Nicholson DW, Metters KM, Pon DJ, Rodger IW.
Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists.
J Pharmacol Exp Ther.
1994;269:891-896 28. Jones TR, Zamboni R, Belley M, et al. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol. 1989;67:17-28[Medline] [Order article via Infotrieve]. 29. Jarvis B, Markham A. Montelukast: a review of its therapeutic potential in persistent asthma. Drugs. 2000;59:891-928[CrossRef][Medline] [Order article via Infotrieve]. 30. Jones TR, Rodger IW. Role of leukotrienes and leukotriene receptor antagonists in asthma. Pulm Pharmacol Ther. 1999;12:107-110[CrossRef][Medline] [Order article via Infotrieve]. 31. Kohrogi H, Iwagoe H, Fujii K, et al. The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma. Respirology. 1999;4:319-323[CrossRef][Medline] [Order article via Infotrieve]. 32. Hamilton A, Faiferman I, Stober P, Watson RM, O'Byrne PM. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol. 1998;102:177-183[CrossRef][Medline] [Order article via Infotrieve].
33.
Heise CE, O'Dowd BF, Figueroa DJ, et al.
Characterization of the human cysteinyl leukotriene 2 receptor.
J Biol Chem.
2000;275:30531-30536 34. Meister B, Grünebach F, Bautz F, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma. Eur J Cancer. 1999;35:445-449. 35. Dexter TM, Testa NG. In vitro methods in hematopoiesis and lymphopoiesis. J Immunol Methods. 1980;38:177-190[CrossRef][Medline] [Order article via Infotrieve]. 36. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol. 1976;(suppl 5):9-15[CrossRef][Medline] [Order article via Infotrieve]. 37. Andersen BR, Brendzel AM. Use of a unique chemiluminescence spectrometer in a study of factors influencing granulocyte light emission. J Immunol Methods. 1978;19:279-287[CrossRef][Medline] [Order article via Infotrieve]. 38. Schopf RE, Mattar J, Meyenburg W, Scheiner O, Hammann KP, Lemmel EM. Measurement of the respiratory burst in human monocytes and polymorphonuclear leukocytes by nitro blue tetrazolium reduction and chemiluminescence. J Immunol Methods. 1984;67:109-117[CrossRef][Medline] [Order article via Infotrieve].
39.
Figueroa DJ, Breyer RM, Defoe SK, et al.
Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes.
Am J Respir Crit Care Med.
2001;163:226-233 40. Vandenberg PA, Ceuppens JL. Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T-lymphocytes with fluo-3, a new fluorescent calcium indicator. J Immunol Methods. 1990;127:197-205[CrossRef][Medline] [Order article via Infotrieve].
41.
Tsien RY, Pozzan T, Rink TJ.
Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.
J Cell Biol.
1982;94:325-334
42.
Kim CH, Broxmeyer HE.
In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment.
Blood.
1998;91:100-110
43.
Howard TH, Meyer WH.
Chemotactic peptide modulation of actin assembly and locomotion in neutrophils.
J Cell Biol.
1984;98:1265-1271
44.
Konig W, Schonfeld W, Raulf M, et al.
The neutrophil and leukotrienes
45.
Rusten LS, Jacobsen SE, Kaalhus O, Vaiby OP, Funderud S, Smeland EB.
Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
Blood.
1994;84:1473-1481
46.
Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM.
Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro.
Blood.
1989;74:1563-1570
47.
Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR.
Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
Blood.
1991;77:1218-1227
48.
Issaad C, Croisille L, Katz A, Vainchenker W, Coulombel L.
A murine stromal cell line allows the proliferaton of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays.
Blood.
1993;81:2916-2924
49.
Wang JF, Park IW, Groopman JE.
Stromal cell-derived factor 1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C.
Blood.
2000;95:2505-2513
50.
Baggiolini M, Dewald B, Moser B.
Interleukin-8 and related chemotactic cytokines
51.
Forster R, Kremmer E, Schubel A, et al.
Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin in various leukocyte subsets: rapid internalization and recycling upon activation.
J Immunol.
1998;160:1522-1531
52.
Kawabata K, Ujikawa M, Edawa T, et al.
A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution.
Proc Natl Acad Sci U S A.
1999;96:5663-5667 53. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999;10:463-471[CrossRef][Medline] [Order article via Infotrieve]. 54. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635-638[CrossRef][Medline] [Order article via Infotrieve]. 55. Kozubik A, Hofmanova J, Pospisil M, Netikova J, Hola J, Lojek A. Effects of drugs inhibiting prostaglandin or leukotriene biosynthesis on postirradiation haematopoiesis in mouse. Int J Radiat Biol. 1994;65:369-377[Medline] [Order article via Infotrieve].
56.
Roberts PJ, Mollapour E, Watts MJ, Linch DC.
Primitive myeloid cells express high levels of phospholipase A(2) activity in the absence of leukotriene release: selective regulation by stem cell factor involving the MAP kinase pathway.
Blood.
1999;94:1261-1272 57. Zou JR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and cerebellar development. Nature. 1998;393:595-599[CrossRef][Medline] [Order article via Infotrieve]. 58. Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 1998;393:591-594[CrossRef][Medline] [Order article via Infotrieve].
© 2001 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  A. M. Boehmler, A. Drost, L. Jaggy, G. Seitz, T. Wiesner, C. Denzlinger, L. Kanz, and R. Mohle The CysLT1 Ligand Leukotriene D4 Supports {alpha}4{beta}1- and {alpha}5{beta}1-Mediated Adhesion and Proliferation of CD34+ Hematopoietic Progenitor Cells J. Immunol., June 1, 2009; 182(11): 6789 - 6798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-S. Maeng, H.-J. Choi, J.-Y. Kwon, Y.-W. Park, K.-S. Choi, J.-K. Min, Y.-H. Kim, P.-G. Suh, K.-S. Kang, M.-H. Won, et al. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLC{beta}2 axis Blood, January 1, 2009; 113(1): 233 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tabatabai, C. Herrmann, G. von Kurthy, M. Mittelbronn, S. Grau, B. Frank, R. Mohle, M. Weller, and W. Wick VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells Brain, October 1, 2008; 131(10): 2579 - 2595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Lemoli and A. D'Addio Hematopoietic stem cell mobilization Haematologica, March 1, 2008; 93(3): 321 - 324. [Full Text] [PDF]
|
|
|
|
|
|
L. Rossi, R. Manfredini, F. Bertolini, D. Ferrari, M. Fogli, R. Zini, S. Salati, V. Salvestrini, S. Gulinelli, E. Adinolfi, et al. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration Blood, January 15, 2007; 109(2): 533 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tabatabai, B. Frank, R. Mohle, M. Weller, and W. Wick Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-{beta}-dependent HIF-1{alpha}-mediated induction of CXCL12 Brain, September 1, 2006; 129(9): 2426 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tabatabai, O. Bahr, R. Mohle, I. Y. Eyupoglu, A. M. Boehmler, J. Wischhusen, J. Rieger, I. Blumcke, M. Weller, and W. Wick Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells Brain, September 1, 2005; 128(9): 2200 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Prinz, C. Gregoire, H. Mollenkopf, E. Aguado, Y. Wang, M. Malissen, S. H.E. Kaufmann, and B. Malissen The Type 1 Cysteinyl Leukotriene Receptor Triggers Calcium Influx and Chemotaxis in Mouse {alpha}{beta}- and {gamma}{delta} Effector T Cells J. Immunol., July 15, 2005; 175(2): 713 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kanaoka and J. A. Boyce Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses J. Immunol., August 1, 2004; 173(3): 1503 - 1510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kimura, A. M. Boehmler, G. Seitz, S. Kuci, T. Wiesner, V. Brinkmann, L. Kanz, and R. Mohle The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells Blood, June 15, 2004; 103(12): 4478 - 4486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Parameswaran, R. Watson, G. M. Gauvreau, R. Sehmi, and P. M. O'Byrne The Effect of Pranlukast on Allergen-induced Bone Marrow Eosinophilopoiesis in Subjects with Asthma Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 915 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chibana, Y. Ishii, T. Asakura, and T. Fukuda Up-Regulation of Cysteinyl Leukotriene 1 Receptor by IL-13 Enables Human Lung Fibroblasts to Respond to Leukotriene C4 and Produce Eotaxin J. Immunol., April 15, 2003; 170(8): 4290 - 4295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Mellor, K. F. Austen, and J. A. Boyce Cysteinyl Leukotrienes and Uridine Diphosphate Induce Cytokine Generation by Human Mast Cells Through an Interleukin 4-regulated Pathway that Is Inhibited by Leukotriene Receptor Antagonists J. Exp. Med., March 4, 2002; 195(5): 583 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fruehauf, K. Srbic, R. Seggewiss, J. Topaly, and A. D. Ho Functional characterization of podia formation in normal and malignant hematopoietic cells J. Leukoc. Biol., March 1, 2002; 71(3): 425 - 432. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
; LTD4, 
. (B)
LTD4-induced intracellular calcium mobilization (expressed as relative
Fluo-3 fluorescence 5 seconds after addition of LTD4) in primary PB
CD34+ progenitors was dose dependent, with an optimum
concentration of 1 µM. (C) The LTD4-induced calcium release in PB
CD34+ cells (expressed as relative Fluo-3 fluorescence 5 seconds after addition of LTD4) was completely blocked by the CysLT1
receptor antagonist MK-571 and partially reduced by PTX. Other
cysteinyl leukotrienes (LTC4, LTE4 at 1 µM) were less effective. The
noncysteinyl leukotriene LTB4 (1 µM) did not induce calcium fluxes in
CD34+ cells. The response of BM-derived CD34+
progenitors was similar to THP-1 cells, whereas the strongest calcium
fluxes were observed in the KG1a cell line. LTD4 induced calcium
mobilization also in mature PMNCs, which, however, was not suppressed
by MK-571 and was less efficient than the noncysteinyl
leukotriene LTB4.
.
role in health and disease.
Eicosanoids.
1990;3:1-22